Brian has made over 4 trades of the Infinity Pharmaceuticals stock since 2008, according to the Form 4 filled with the SEC. Most recently Brian exercised 200,000 units of INFI stock worth $724,000 on 13 June 2018.
The largest trade Brian's ever made was exercising 200,000 units of Infinity Pharmaceuticals stock on 13 June 2018 worth over $724,000. On average, Brian trades about 6,834 units every 109 days since 2008. As of 13 June 2018 Brian still owns at least 245,738 units of Infinity Pharmaceuticals stock.
You can see the complete history of Brian Schwartz stock trades at the bottom of the page.
Brian's mailing address filed with the SEC is C/O CYCLACEL PHARMACEUTICALS, INC.,, 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922.
Over the last 18 years, insiders at Infinity Pharmaceuticals have traded over $485,846,497 worth of Infinity Pharmaceuticals stock and bought 22,639,120 units worth $175,155,554 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., eMedical Co L.P. Rosebay. On average, Infinity Pharmaceuticals executives and independent directors trade stock every 70 days with the average trade being worth of $14,976. The most recent stock trade was executed by Adelene Q Perkins on 8 September 2023, trading 768,133 units of INFI stock currently worth $15,363.
the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation. strategic alliances building on its strengths in innovative small molecule drug discovery and development, infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline. business and scientific expertise the company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business
Infinity Pharmaceuticals executives and other stock owners filed with the SEC include: